Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Adverse events: hypertension · adults with FSGS

1 finding from 1 review

Interventions for focal segmental glomerulosclerosis in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 187 participants
Very low

Adverse events: hypertension · SSNS in children

Mycophenolate mofetil showed no clear difference in adverse effects: hypertension compared with cyclosporin (low certainty).

1 finding from 1 review

Adverse events: hypertension · SSNS in children

It is very uncertain whether alkylating agents changes adverse effects: hypertension compared with cyclosporin (very low certainty).

1 finding from 1 review